Wells Fargo’s SOC Telemed, Inc. Class A Common Stock TLMD Stock Holding History

Wells Fargo’s Portfolio TLMD Stock Details TLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-21,072	Closed	-$63K	–	8028
2022 Q1	$63K	Sell	21,072 -35,343	-63%	-$77.8K	﹤0.01%	5546
2021 Q4	$72K	Buy	56,415 +16,246	+40%	+$32.6K	﹤0.01%	5798
2021 Q3	$90K	Buy	40,169 +6,953	+21%	+$25K	﹤0.01%	5431
2021 Q2	$189K	Sell	33,216 -1,035	-3%	-$6.89K	﹤0.01%	5055
2021 Q1	$216K	Buy	34,251 +30,606	+840%	+$230K	﹤0.01%	5119
2020 Q4	$28K	Buy	3,645 +1,331	+58%	+$11.8K	﹤0.01%	5772
2020 Q3	$23K	Buy	+2,314	New	+$23.9K	﹤0.01%	5726

Wells Fargo's TLMD Position: Q2 2022 in Review

Wells Fargo sold out of SOC Telemed, Inc. Class A Common Stock (TLMD) in Q2 2022, closing a stake of 21,072 shares — an estimated $63K sold.

Wells Fargo first reported a position in TLMD in Q3 2020 and held it in 7 quarters. The position peaked at $216K in Q1 2021. 0 funds tracked by Wall St. Rank hold TLMD as of Q2 2022.

Wells Fargo reported no remaining SOC Telemed, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
Wells Fargo sold 21,072 SOC Telemed, Inc. Class A Common Stock shares in Q2 2022, an estimated $63K.
Wells Fargo first reported a position in SOC Telemed, Inc. Class A Common Stock in Q3 2020 and held it in 7 quarters.
Wells Fargo's SOC Telemed, Inc. Class A Common Stock position peaked at $216K in Q1 2021.
0 funds tracked by Wall St. Rank held SOC Telemed, Inc. Class A Common Stock as of Q2 2022.

Based on Wells Fargo's 13F filing for Q2 2022, filed 12 Aug 2022.